Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination

Open Access

Peer-reviewed

Research Article

Ben Buelow,

Affiliation Departments of Pediatrics and Immunology, University of Washington, Seattle Children's Hospital Research Institute, Seattle, Washington, United States of America
⨯
Andrew M. Scharenberg

* E-mail: andrewms@u.washington.edu

Affiliation Departments of Pediatrics and Immunology, University of Washington, Seattle Children's Hospital Research Institute, Seattle, Washington, United States of America
⨯

Reader Comments (0)

Cloning
Is the Subject Area "Cloning" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Gene targeting
Is the Subject Area "Gene targeting" applicable to this article?

Thanks for your feedback.
B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Chickens
Is the Subject Area "Chickens" applicable to this article?

Thanks for your feedback.
Estrogens
Is the Subject Area "Estrogens" applicable to this article?

Thanks for your feedback.